By combining human tissue models with explainable AI, researchers can analyse complex patient data to identify which treatments work best for which patients. First applied to inflammatory bowel disease, this approach could improve clinical trial success rates across many diseases.
Recent publication unveils advances in precision drug delivery using synthetic virus-like particles
The Science and Technology Facilities Council’s (STFC) Hartree Centre, IBM Research and the National Physical Laboratory collaborated to advance drug delivery methods by leveraging synthetic virus-like particles